Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against F5, Inc. regarding possible violations of federal securities laws and unlawful business practices following a significant security breach [1][2]. Investigation Details - On October 15, 2025, F5 disclosed that a sophisticated nation-state threat actor had gained unauthorized access to its systems, maintaining long-term access to critical areas including the BIG-IP product development environment [2]. - The breach resulted in the exfiltration of files, including portions of the BIG-IP source code and information on undisclosed vulnerabilities, leading to a decline in F5's stock price by $35.40, or approximately 10.70%, from $330.75 to $295.35 between October 15 and October 16, 2025 [2]. Next Steps - Investors who purchased F5 shares and experienced losses are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against Synopsys, Inc. regarding possible violations of federal securities laws and unlawful business practices [1][2]. Investigation Details - The investigation is focused on whether Synopsys has engaged in any unlawful activities that may have affected its stockholders [2]. - Investors who have suffered losses and are interested in discussing their legal rights are encouraged to contact the law firm [3]. Company Performance - On September 9, 2025, Synopsys reported its financial results for Q3 2025, indicating that its IP business underperformed expectations [6]. - The CEO of Synopsys expressed a more conservative outlook for Q4 while guiding for another year of profitable growth [6]. - Following the announcement, Baird downgraded Synopsys's rating from Outperform to Neutral and reduced its price target from $670 to $535 [6]. - As a result of this news, Synopsys's stock price dropped by $216.59, or 35.84%, closing at $387.78 per share on September 10, 2025 [6].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Semler Scientific Inc. for possible violations of federal securities laws and unlawful business practices [1][2]. Investigation Details - Semler disclosed in its Form 10-K filed on February 28, 2025, that it received a civil investigative demand from the U.S. Department of Justice (DOJ) in July 2017 regarding reimbursement claims for its QuantaFlo device [2]. - The company has faced multiple requests for information from the DOJ over the years, with significant discussions occurring in February 2025 that did not lead to a settlement [2]. - Following the disclosure of potential legal risks, Semler's stock price fell from $42.92 to $38.89, a decline of $4.03 per share [2]. Next Steps - Investors who purchased Semler shares and experienced losses are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a law firm recognized for representing investors in various complex litigations across state and federal courts [4].

Core Viewpoint - Centene Corporation is facing potential legal claims regarding violations of federal securities laws and unlawful business practices following a significant drop in stock price after withdrawing its 2025 earnings guidance [1][2]. Group 1: Company Performance - On July 2, 2025, Centene's stock price fell over 39.5% during intraday trading after the company announced the withdrawal of its 2025 earnings guidance due to higher-than-expected costs related to Medicaid enrollees and underperformance in its Affordable Care Act plans [2]. - The company indicated that its Medicaid business has seen an increase in medical cost trends in areas such as behavioral health, home health, and high-cost drugs [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Centene on behalf of its stockholders, focusing on whether the company has violated federal securities laws [1]. - The law firm is reaching out to long-term stockholders who may have suffered losses or have information regarding these claims [3].

Core Viewpoint - Hallador Energy Company is under investigation for potential violations of federal securities laws and unlawful business practices following the termination of an exclusivity agreement with a datacenter developer, which led to a significant drop in its stock price [1][2]. Company Developments - On May 23, 2025, Hallador announced the termination of its exclusivity agreement with a datacenter developer regarding a potential power supply deal, which has raised concerns among investors [2]. - Following the announcement, Hallador's stock price decreased by $1.38 per share, representing a 7.33% decline, closing at $17.45 per share [2]. Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Hallador stockholders who may have suffered losses due to the company's actions [1][3]. - The law firm is seeking information from long-term stockholders and those who have acquired Hallador shares regarding their rights and interests in this matter [3].

Company Overview - Humana Inc. is a for-profit health insurance company that provides Medicare Advantage, individual and group insurance, pharmacy benefit management, and integrated care services through its CenterWell network [3] Allegations of Wrongdoing - The Department of Justice filed a False Claims Act complaint against Humana on May 1, 2025, alleging that from 2016 to at least 2021, the company paid illegal kickbacks to health insurance brokers for enrollments into its Medicare Advantage plans [4] Market Reaction - Following the announcement of the DOJ lawsuit, Humana's stock price fell by $6.20 per share, or 2.36%, closing at $256.04 per share on May 1, 2025 [5]

Core Viewpoint - EchoStar Corporation is under investigation by the Federal Communications Commission (FCC) for potential non-compliance with federal requirements related to building a nationwide 5G network, which has led to a significant drop in its stock price [2]. Group 1: Investigation and Legal Actions - Bragar Eagel & Squire, P.C. is investigating potential claims against EchoStar on behalf of its stockholders regarding possible violations of federal securities laws and other unlawful business practices [1]. - The FCC's notification of the investigation has resulted in EchoStar's stock price falling by $4.01, or 16.6%, closing at $20.18 per share on May 12, 2025, indicating investor injury [2]. Group 2: Investor Communication - The law firm is reaching out to EchoStar stockholders who may have suffered losses, encouraging them to contact the firm for more information regarding their rights and potential claims [3].

Core Viewpoint - Horizon Technology Finance Corporation is under investigation for potential violations of federal securities laws and unlawful business practices, following disappointing financial results that led to a significant drop in stock price [1][2][3]. Financial Performance - For the fourth quarter and full year ended December 31, 2024, Horizon reported total investment income of $23.5 million, which was below the consensus estimate of $26.1 million and represented a decline from both the previous quarter and year-over-year [2]. - The net asset value per share decreased to $8.43 from $9.06 in the previous quarter, attributed to "stressed investments" by the CEO [2]. Stock Market Reaction - Following the announcement of the financial results, Horizon's stock price fell by $0.96 per share, or 9.95%, closing at $8.65 per share on March 5, 2025 [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against AppLovin Corporation for alleged violations of federal securities laws, encouraging affected investors to come forward before the May 5, 2025 deadline for lead plaintiff applications [1][3]. Group 1: Allegations Against AppLovin - The complaint alleges that AppLovin and its executives made false and misleading statements regarding the company's financial growth and stability, particularly concerning the launch of its AXON 2.0 digital ad platform and the use of AI technologies [3]. - Defendants reportedly provided optimistic financial results and guidance while engaging in dishonest advertising practices [3]. - The truth about AppLovin's practices emerged on February 26, 2025, when reports indicated that the company was reverse engineering advertising data from Meta Platforms and using manipulative tactics to inflate ad performance metrics [4]. Group 2: Stock Price Impact - Following the revelation of these practices, AppLovin's stock price fell from $377.06 per share on February 25, 2025, to $331.00 per share on February 26, 2025, reflecting a significant decline in investor confidence [5]. Group 3: Legal Proceedings - The lead plaintiff in the class action lawsuit will be the investor with the largest financial interest who is also representative of the class members, with the option for any class member to apply for this role [6]. - Faruqi & Faruqi encourages anyone with information regarding AppLovin's conduct, including whistleblowers and former employees, to reach out to the firm [7].